<?xml version="1.0" encoding="UTF-8"?>
<p>O.G.P. received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 614725-PATHPHYLODYN. A.J.T. is supported by funding from NIH/NIAID (U19AI089674), the Bill and Melinda Gates Foundation (OPP110642749446, 1032350), the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, Wellcome Trust Sustaining Health Grant, 106866/Z/15/Z, and the Fogarty International Center, National Institutes of Health. P.L. acknowledges funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 278433-PREDEMICS and ERC Grant agreement no. 260864, as well as funding, the from Onderzoeksfonds KU Leuven/Research Fund KU Leuven.</p>
